Announcement PDF 10 July 2020 Dear Sir/Madam RACE ONCOLOGY LIMITED (ACN 149 318 749) – UPCOMING GENERAL MEETING Race Oncology Limited (ACN 149 318 749) (ASX:RAC) (Company) will be holding a general meeting at 10.30 am AEST on 11 August 2020 (the Meeting). The Company is closely monitoring the impact of the COVID-19 virus in Victoria and following guidance from the Federal and State Governments, the Meeting will be held virtually. There will not be a physical meeting where shareholders can attend in person. In accordance with temporary modifications to the Corporations Act 2001 (Cth) under the Corporations (Coronavirus Economic Response) Determination (No. 1) 2020, the Company is not sending hard copies of the Notice of Meeting to shareholders. The Notice of Meeting documents can be viewed and downloaded from the website link set out below: https://raceoncology.com/investors/ If you wish to virtually attend the Meeting (which will be broadcast as a live webinar), please pre-register in advance for the virtual Meeting here: https://us02web.zoom.us/webinar/register/WN_e7n5dITIRhejw-l8jVqIjw After registering, you will receive a confirmation containing information on how to attend the virtual Meeting. To attend the Meeting and vote virtually, shareholders will need to access www.investor.automic.com.au. You will be able to login to your Automic account with your username and password. If live voting for the virtual Meeting is open, click on ‘Meeting open for voting’ and follow the steps. Shareholders who do not have an account with Automic are strongly encouraged to register for an account as soon as possible and well in advance of the Meeting to avoid any delays on the day of the Meeting. To create an account, visit https://investor.automic.com.au/#/home, click on ‘register’ and follow the steps. Shareholders will be able to participate in the Meeting by: (a) voting their Shares if possible, prior to the Meeting by lodging the proxy form attached to the Notice by no later than 10.30 am AEST on 9 August 2020; (b) lodging questions, if possible, in advance of the Meeting by emailing the questions to pwebse@governancecorp.com.au by no later than 9 August 2020 and/or (c) attending the Meeting by the online Meeting platform. The Company encourages shareholders to submit their votes and questions in advance of the Meeting as this will provide management with the best opportunity to prepare for the Meeting. However, votes and questions may also be submitted during the Meeting. All questions will be submitted to the Chair, who will then direct them to be answered by the most appropriate member of management during the Meeting. Further details of the online Meeting facilities, including detailed instructions on how to access such facilities are included in the Notice of Meeting. Race Oncology Ltd ABN 61 149 318 749 Registered office: L40, 140 William St, Melbourne VIC Australia 3000 www.raceoncology.com If you have nominated an email address and have elected to receive electronic communications from the Company, you will also receive an email to your nominated email address with a link to an electronic copy of the important Meeting documents. In order to be able to receive electronic communications from the Company in the future, please update your shareholder details online at https://investor.automic.com.au/#/home. Once logged in you can also lodge your proxy vote online by clicking on the “Vote” tab. If you are unable to access any of the important Meeting documents online please contact the Company Secretary, Peter Webse, on +61 8 6377 8043 or via email at pwebse@governancecorp.com.au. Authorised for release by the Board. Peter Webse Company Secretary